Diseases, Conditions, Syndromes

Pyramax receives positive opinion from the EMA

Pyramax, a fixed-dose combination of pyronaridine and artesunate, becomes the first antimalarial to be granted a positive scientific opinion from the European Medicines Agency (EMA) under Article 58. This once daily, 3-day ...

Genetics

Gene clues point to Cambodia for resistant malaria

Gene analysis of malaria parasites has pinpointed western Cambodia as the hotspot of strains that are dangerously resistant to artesiminin, the frontline drug against the disease, scientists said on Sunday.

Diseases, Conditions, Syndromes

Scientists find new way to fight Malaria drug resistance

An anti-malarial treatment that lost its status as the leading weapon against the deadly disease could be given a new lease of life, with new research indicating it simply needs to be administered differently.

Medications

Side effects seen with use of chloroquine against COVID-19

(HealthDay)—The use of the antimalarial drug chloroquine to treat COVID-19 patients has been halted at several Swedish hospitals due to reported side effects such as cramps and loss of peripheral vision. Sahlgrenska University ...

Diseases, Conditions, Syndromes

New evidence supports radical treatment of widespread form of malaria

Darwin, Australia: A team of malaria experts from a large international research collaboration has published results supporting the need for a radical cure strategy to tackle one of the most debilitating forms of malaria ...

Arthritis & Rheumatism

Metabolic syndrome common in young women with lupus

(HealthDay)—Metabolic syndrome is common in young, premenopausal women with systemic lupus erythematosus (SLE), and chloroquine appears to protect against metabolic syndrome in these women, according to a study published ...

Diseases, Conditions, Syndromes

Treatment of chloroquine poisoning

Research by Bangor University's Professor Dyfrig Hughes has provided important evidence on the safety of treatments that are being tested for use in COVID-19.

Oncology & Cancer

Malaria medicine chloroquine inhibits tumor growth and metastases

A recent study by investigators at VIB and KU Leuven has demonstrated that chloroquine also normalizes the abnormal blood vessels in tumors. This blood vessel normalization results in an increased barrier function on the ...

page 3 from 6